Granted Patent
B2
US 12697402 · App. 17/432,070 · Granted Aug 4, 2026
Detection of colonic neoplasia in vivo using near-infrared peptide targeted against overexpressed cMet
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The disclosure provides peptides, including labeled peptides, that selectively bind to the cMet protein. The disclosure also provides methods of detecting dysplastic cells and tissue, e.g., in the colon, providing early identification of precancerous and cancerous tissue.
Claims (1)
1 . A peptide consisting of the amino acid sequence QQTNWSL set forth in SEQ ID NO:1.